Cost-benefit analysis of chlorhexidine gluconate dressing in the prevention of catheter-related bloodstream infections

Infection Control and Hospital Epidemiology

Volumn 25, Issue 8, 2004, Pages 668-674

  Crawford, Albert G ^a   Fuhr Jr , Joseph P ^a,b   Rao, Bhaskar ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b WIDENER UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORHEXIDINE GLUCONATE;

ANTIMICROBIAL ACTIVITY; ARTICLE; BACTEREMIA; CATHETER INFECTION; CENTRAL VENOUS CATHETER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST BENEFIT ANALYSIS; DECISION THEORY; HUMAN; INFECTION PREVENTION; MORTALITY; RANDOMIZED CONTROLLED TRIAL; SENSITIVITY ANALYSIS; UNITED STATES; WOUND DRESSING;

ANTI-INFECTIVE AGENTS, LOCAL; BANDAGES; CATHETERIZATION; CHLORHEXIDINE; COST-BENEFIT ANALYSIS; DECISION SUPPORT TECHNIQUES; EQUIPMENT CONTAMINATION; HEALTH CARE COSTS; HUMANS; SEPSIS; SURVIVAL ANALYSIS;

EID: 4143100154     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/502459     Document Type: Article

References (20)

1. Veenstra DL, Saint S, Sullivan SD. Cost-effectiveness of antiseptic-impregnated central venous catheters for the prevention of catheter-related bloodstream infection. JAMA 1999;282:554-560.
2. O'Grady NP, Alexander M, Dellinger EP, Gerberding JL, Heard SO, Maki DG. Guidelines for the prevention of intravascular catheter-related infections. MMWR 2002;51:1-26.
3. Kluger DM, Maki DG. The relative risk of intravascular device related bloodstream infections in adults. Presented at the 39th Interscience Conference on Antimicrobial Agents and Chemotherapy; September 26-29, 1999; San Francisco, CA.
4. Mermel L. Prevention of intravascular catheter-related infections. Ann Intern Med 2000;132:391-402.
5. Saint S, Veenstra DL, Lipsky BA. The clinical and economic consequences of nosocomial central venous catheter-related infection: are antimicrobial catheters useful? Infect Control Hosp Epidemiol 2000;21:375-380.
6. Wenzel RP, Edmond MB, The impact of hospital-acquired bloodstream infections. Emerg Infect Dis 2001;7:174-177.
7. Byers KE, Adal KA, Anglim AM, Farr BM. Case fatality rate for catheter-related bloodstream infections: a meta-analysis. Infect Control Hosp Epidemiol 1995;16(part 2, suppl):23. Abstract.
8. Arnow P, Quimonsing E, Beach M. Consequences of intravascular catheter sepsis. Clin Infect Dis 2000;16:778-784.
9. Martin MA, Pfaller MA, Wenzel RP. Coagulase-negative staphylococcal bacteremia: mortality and hospital stay. Ann Intern Med 1989;110:9-16.
10. Pittet D, Tarara D, Wenzel RP. Nosocomial bloodstream infection in critically ill patients. JAMA 1994;271:1598-1601.
11. Smith RL, Meixler SM, Simberkoff MS. Excess mortality in critically ill patients with nosocomial bloodstream infections. Chest 1991;100:164-167.
12. Pittet D. Nosocomial bloodstream infections in the critically ill. JAMA 1994;272:1820.
13. Dimick JB, Pelz RK, Consunji R, Swoboda SM, Hendrix CW, Lipsett PA. Increased resource use associated with catheter-related blood-stream infection in the surgical intensive care unit. Arch Surg 2001;136:229-234.
14. Rello J, Ochagavia A, Sabanes E. Evaluation of outcome of intravenous catheter-related infections in critically ill patients. Am J Respir Crit Care Med 2000;162:1027-1030.
15. Chiacchierini RP, Hua S, Genthner D. Final Report: An Evaluation of Biopatch Antimicrobial Dressing Compared to Routine Standard of Care in the Prevention of Catheter-Related Blood Stream Infection, Dennis Maki and Leonard Mermel, Principal Investigators. Somerville, NJ: Johnson & Johnson Wound Management; 1999.
16. Maki DG, Mermel LA, Kluger D, Narins L, Knasinski V, Parenteau S. The Efficacy of a Chlorhexidine-Impregnated Sponge (Biopatch™) for the Prevention of Intravascular Catheter-Related Infection: A Prospective, Randomized, Controlled, Multicenter Study. Washington, DC: American Society for Microbiology; 2000.
17. Wentzel C, Moyer R, Butong E, Good J. Pennsylvania Inpatient Data, 2003 1st Quarter: Data Notes. Harrisburg, PA: Pennsylvania Health Care Cost Containment Council; 2003.
18. Collin GR. Decreasing catheter colonization through the use of an antiseptic impregnated catheter. Chest 1999;115:1632-1640.
19. Darouiche RO, Raad II, Heard SO. A comparison of two anti-microbial- impregnated central venous catheters. N Engl J Med 1999;340:1-8,
20. Soufir L, Timsit JF, Mahe C, Carlet J, Regnier B, Chevret S. Attributable morbidity and mortality of catheter-related septicemia in critically ill patients: a matched, risk-adjusted, cohort study. Infect Control Hosp Epidemiol 1999;20:396-401.